INVEGA
NDC 50458-554, paliperidone, tablet, extended release, from Janssen Pharmaceuticals, Inc..
- Product NDC
- 50458-554
- Status
- Listed
- Labeler
- Janssen Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021999
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50458-554 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALIPERIDONE1.5 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/7b8e5b26-b9e4-4704-921b-3c3c0d159916
Use it
Look up 50458-554 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50458-554 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50458-554. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.